UK Attacks Pandemic With Funding For Drug And Vaccine Trials
Biotech Industry Body Assembles COVID-19 Task Force
Efforts are under way in the UK on many fronts to develop new treatments and vaccines for coronavirus infection, including researching new uses of existing products and clinical trials of new vaccines.
You may also be interested in...
Pfizer and BioNTech's COVID-19 vaccine picks up its third emergency authorization, with all eyes now on the final decision from the US FDA. Elsewhere, there are changes at the UK's vaccine taskforce, while Korea is moving ahead with vaccine development plans.
The UK government believes its new Vaccine Taskforce will be essential in coordinating efforts to rapidly accelerate the development and manufacture of a potential new coronavirus vaccine.
The UK’s Medicines and Healthcare products Regulatory Agency says that any increase in clinical trial protocol deviations in relation to coronavirus outbreak will not constitute a serious breach.